Paul Melone

Corporate Officer/Principal bei

Third Rock Ventures LLC

Consumer Services

Health Technology

Finance

Profil

Paul Melone is Senior Director at Third Rock Ventures LLC since 2023.
Mr. Melone was Director of IT at Infinity Pharmaceuticals, Inc. from 2010 to 2023.
Education includes undergraduate degrees from The Catholic University of America in 1995 and St. Anselm College in 1994.

Aktive Positionen von Paul Melone

Unternehmen	Position	Beginn
Third Rock Ventures LLC Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor.	Corporate Officer/Principal	01.01.2023

Alle aktiven Positionen von Paul Melone

Ehemalige bekannte Positionen von Paul Melone

Unternehmen	Position	Ende
INFINITY PHARMACEUTICALS, INC.	Private Equity Investor	01.02.2023

Sehen Sie sich die Erfahrung von Paul Melone im Detail an

Ausbildung von Paul Melone

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul Melone im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer	Health Technology
The Catholic University of America The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
St. Anselm College St. Anselm College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Third Rock Ventures LLC Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor.	Finance